Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines (Q40896381)

24 September 2017

title

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines (English)

1 reference

24 September 2017

1 reference

T H Scott-Taylor

1 reference

24 September 2017

R Pettengell

1 reference

24 September 2017

I Clarke

1 reference

24 September 2017

G Stuhler

1 reference

24 September 2017

M C La Barthe

1 reference

24 September 2017

P Walden

1 reference

24 September 2017

A G Dalgleish

1 reference

24 September 2017

language of work or name

1 reference

1 March 2000

1 reference

Biochimica et Biophysica Acta

24 September 2017

published in

1 reference

24 September 2017

volume

1500

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

265-279

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

24 September 2017

1 reference

7 January 2021

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Perspectives on the role of MHC antigens in normal and malignant cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

MHC antigens on human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Identifying strategies for immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Mechanically facilitated cell-cell electrofusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Detection and quantitation of cell-cell electrofusion products by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Electric field-mediated fusion and related electrical phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Dendritic cell-based immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

1 reference

7 January 2021

Kinetics and mechanism of cell membrane electrofusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Studies on the mechanism of polyethylene glycol-mediated cell fusion using fluorescent membrane and cytoplasmic probes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Characterization of electric field-induced fusion in erythrocyte ghost membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Divalent cations, phospholipid asymmetry and osmotic swelling in electrically-induced lysis, cell fusion and giant cell formation with human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Magneto-electro-fusion of human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Nuclear membrane fusion in electrofused mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Electric pulse-induced fusion of 3T3 cells in monolayer culture

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Monoclonal antibody production by receptor-mediated electrically induced cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Hybridoma production by simplified avidin-mediated electrofusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Characterization of PEG-mediated electrofusion of human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Electrofusion of fibroblasts on the porous membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Facilitation of electrofusion of mouse lymphoma cells by the proteolytic action of proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Kinetics of ultrastructural changes during electrically induced fusion of human erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Efficient generation of stable antibody forming hybridoma cells by electrofusion

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Electrofusion of cell-size liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Action of polyethylene glycol on the fusion of human erythrocyte membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

The resealing process of lipid bilayers after reversible electrical breakdown.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Fusion of mammalian cells in culture is obtained by creating the contact between cells after their electropermeabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

A long-lived fusogenic state is induced in erythrocyte ghosts by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2899%2900108-8

7 January 2021

10.1016/S0925-4439(99)00108-8

Identifiers

DOI

1 reference

24 September 2017

1 reference